Free Trial

OncoCyte (OCX) SEC Filings & 10K Form

OncoCyte logo
$2.71 +0.04 (+1.50%)
(As of 11/22/2024 ET)

Recent OncoCyte SEC Filings

DateFilerForm TypeView
10/24/2024
11:13 AM
BIO-RAD LABORATORIES, INC. (Filed by)
BIO-RAD LABORATORIES, INC. (Filed by)
OncoCyte (Subject)
Form SC 13G/A
10/22/2024
3:12 PM
OncoCyte (Filer)
Form 424B3
10/21/2024
11:15 PM
OncoCyte (Filer)
Form EFFECT
10/18/2024
3:55 PM
OncoCyte (Filer)
Form S-3/A
10/16/2024
4:16 PM
OncoCyte (Filer)
Form S-3
Registration statement under Securities Act of 1933  
10/15/2024
3:15 PM
James Andrea S. (Reporting)
OncoCyte (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
3:22 PM
OncoCyte (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/09/2024
4:03 PM
OncoCyte (Subject)
SMITH PATRICK W (Filed by)
Form SC 13G
10/04/2024
6:40 PM
James Andrea S. (Reporting)
OncoCyte (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
6:00 PM
BRADSHER NEAL C (Reporting)
BROADWOOD CAPITAL INC (Reporting)
BROADWOOD PARTNERS, L.P. (Reporting)
OncoCyte (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
5:05 AM
OncoCyte (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/25/2024
3:09 PM
OncoCyte (Filer)
Form DEF 14A
08/09/2024
5:25 AM
OncoCyte (Filer)
Form 424B5
08/09/2024
5:37 AM
OncoCyte (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
11:15 PM
OncoCyte (Filer)
Form EFFECT
08/08/2024
3:27 PM
OncoCyte (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/05/2024
3:01 PM
OncoCyte (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2024
8:00 PM
OncoCyte (Issuer)
SILVERMAN LOU (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
8:00 PM
Last Andrew J. (Reporting)
OncoCyte (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
8:00 PM
Arno Andrew (Reporting)
OncoCyte (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
3:47 PM
James Andrea S. (Reporting)
OncoCyte (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/24/2024
3:49 PM
James Andrea S. (Reporting)
OncoCyte (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
10:26 AM
OncoCyte (Filer)
Form 424B3
05/22/2024
11:15 PM
OncoCyte (Filer)
Form EFFECT
05/17/2024
4:11 PM
OncoCyte (Filer)
Form S-3/A
05/15/2024
3:21 PM
OncoCyte (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2024
4:31 PM
OncoCyte (Filer)
Form S-3
Registration statement under Securities Act of 1933  
04/29/2024
4:23 PM
OncoCyte (Filer)
Form DEF 14A
04/22/2024
12:30 PM
BIO-RAD LABORATORIES, INC. (Filed by)
BIO-RAD LABORATORIES, INC. (Filed by)
OncoCyte (Subject)
Form SC 13G
04/15/2024
8:55 PM
OncoCyte (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
04/15/2024
6:21 PM
BRADSHER NEAL C (Reporting)
BROADWOOD CAPITAL INC (Reporting)
BROADWOOD PARTNERS, L.P. (Reporting)
OncoCyte (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2024
6:26 PM
BROADWOOD PARTNERS, L.P. (Filed by)
OncoCyte (Subject)
Form SC 13D/A
04/15/2024
5:02 AM
Arno Andrew (Reporting)
OncoCyte (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2024
5:04 AM
OncoCyte (Issuer)
Riggs Josh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/12/2024
5:04 AM
OncoCyte (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/11/2024
4:28 PM
OncoCyte (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
2:47 PM
AWM Investment Company, Inc. (Filed by)
OncoCyte (Subject)
Form SC 13G/A
01/23/2024
3:39 PM
OncoCyte (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:OCX) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners